Clinical Trial Update: Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetic interactions between capecitabine and BMS-247550 in patients with advanced malignancies; the update reports on how each …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• BMS-247550
• Capecitabine (capecitabine)

Snippet

Sponsor: R-Pharm | Conditions: Advanced Solid Tumors, Neoplasms | Phase 1 | Status: COMPLETED